New osteoporosis drug Evenity approved
The U.S. Food and Drug Administration this past spring approved a drug called Evenity (romosozumab-aqqg) to treat osteoporosis in postmenopausal women at high risk of
American Bone Health has closed. However, on October 1, 2023, we joined forces with the Bone Health and Osteoporosis Foundation (BHOF) so that BHOF could continue offering all of the important programs and services created by American Bone Health. Please visit www.bonehealthandosteoporosis.
The U.S. Food and Drug Administration this past spring approved a drug called Evenity (romosozumab-aqqg) to treat osteoporosis in postmenopausal women at high risk of
The American Bone Health Fracture Risk Calculator™ estimates fracture risk for women and men over age 45.
251 18th Street S, Suite 630, Arlington, VA, 22202 · 1(800) 231-4222
info@bonehealthandosteoporosis.org
© Copyright BHOF 2023
EIN: 36-3350532